RIGL Rigel Pharma Net earnings per share growth forecast for next year
Although marketing costs are already priced in, Rigel Pharmaceuticals (RIGL) is increasing revenues through the sale of oncology drugs. This chart of expected EPS growth for the coming year reflects asset revaluation dynamics, where the value of 36.60 expresses the metric level. Financial success is based on Tavalisse sales, while the strategy relies on the discovery of new molecules to combat rare cancers.
RIGL (rigel.com): analytical breakdowns and indicator data
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital Rigel Pharmaceuticals|RIGL - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Rigel Pharmaceuticals, Inc.|RIGL - Company Total Indebtedness|Debts to Book Capitalization Rigel Pharmaceuticals|RIGL - Long-Term Debt|Company Short-Term Debt Rigel Pharmaceuticals|Quick Liquidity Indicator rigel.com
- earnings and valuation multiples information:
RIGL - Final Profit|Expected Profit Rigel Pharmaceuticals|RIGL - Market Cap to Net Income|Forward P/E Multiple Rigel Pharmaceuticals|RIGL - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Rigel Pharmaceuticals|RIGL - Operating profit EBITDA|Earnings per share for the last twelve months Rigel Pharmaceuticals|RIGL - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months rigel.com|RIGL - Net earnings per share growth this year|Earnings growth forecast for next year Rigel Pharmaceuticals
- total revenue and sales volume data:
Analysis of all company metrics:Rigel Pharmaceuticals Inc, RIGL
The absence of in-house manufacturing facilities at Rigel Pharmaceuticals (RIGL) makes the forward-looking assessment of net income dynamics a key indicator of how external contractor efficiency impacts capitalization. This metric captures a shift in institutional earnings expectations for the coming year, where any downward revision in forecasts necessitates preemptive growth to restore value. Sharp spikes in this indicator signal a risk of asset devaluation if inflated targets are not achieved.
Competitors of Rigel Pharmaceuticals
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Expected earnings per share trend next year GRFS (Grifols Biemat)|ADPT: Earnings growth forecast for next year|CLDX - Consensus forecast of earnings per share growth for next year|AUPH (Aurinia Pharmaceuticals Inc.) - Earnings growth forecast for next year|BCRX - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year VERA|DNTH - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Pharvaris N.V. PHVS|abcellera.com - Net earnings per share growth forecast for next year|TRML: Expected earnings per share growth for next year|Expected earnings per share trend next year PGEN (Precigen Inc)|Pharming (PHAR) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year NKTR (Nektar Corp)|UPB (Upstream Bio Inc) - Earnings growth forecast for next year|ZBIO: Expected earnings per share trend next year|Earnings growth forecast for next year IMNM|Earnings growth forecast for next year Gossamer Bio Inc (GOSS)|Net earnings per share growth forecast for next year KalVista Pharmaceuticals Inc KALV|Expected earnings per share trend next year SEPN|PVLA - Net earnings per share growth forecast for next year|savarapharma.com (SVRA) - Expected earnings per share growth for next year|ANAB: Earnings growth forecast for next year|Astria Therapeutics Inc (ATXS) - Earnings growth forecast for next year|ENGN (enGene Bio) - Earnings growth forecast for next year|Expected earnings per share growth for next year RAPT Therapeutics Inc. (RAPT)|Earnings growth forecast for next year JBIO|ACRS - Expected net earnings per share growth next year|Kyverna Therapeutics, Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year Tiziana Life Sciences Ltd. TLSA|CABA: Expected earnings per share growth for next year|Ventyx Biosciences, Inc - Projected earnings per share increase next year|THTX: Earnings growth forecast for next year|AVTX - Consensus forecast of earnings per share growth for next year|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year Agenus, Inc. (AGEN)|Earnings growth forecast for next year CLYM|Earnings growth forecast for next year Zura Bio Ltd (ZURA)|Net earnings per share growth forecast for next year aTyr Pharma, Inc. ATYR|Adagene Inc - Net earnings per share growth forecast for next year|IMA - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Shattuck Labs, Inc. STTK|equilliumbio.com (EQ) - Net earnings per share growth forecast for next year|Connect Biopharma Holdings Limited - Expected earnings per share trend next year|IMUX (Immunic Therapeutics) - Earnings growth forecast for next year|Atara Biotherapeutics Inc (ATRA) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year IFRX|X4 Pharmaceuticals Inc. (XFOR) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year Adicet Bio, Inc. ACET|Celularity Inc - Net earnings per share growth forecast for next year|INMB - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year BRNS|KZR: Earnings growth forecast for next year|SAB Biotherapeutics Inc. - Expected earnings per share trend next year|AKTX (Akari Therapeutics plc) - Earnings growth forecast for next year|Earnings growth forecast for next year Enlivex Therapeutics, Ltd.|Net earnings per share growth forecast for next year Q32 Bio Inc. (QTTB)|GOVX (geovax.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Edesa Biotech EDSA|IBIO - Expected earnings per share growth for next year|Carisma Tx - Earnings growth forecast for next year|XTLB - Earnings growth forecast for next year|BOLT (boltbio.com) - Expected earnings per share growth for next year|HCW Biologics - Expected earnings per share trend next year|APVO (Aptevo Therapeutics, Inc.) - Earnings growth forecast for next year|AIM ImmunoTech, Inc. (AIM) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Aditxt (ADTX)|Expected earnings per share growth for next year GRI Bio Corporation GRI|Net earnings per share growth forecast for next year XORTX Therapeutics Inc. XRTX|HIND - Expected earnings per share growth for next year|REVB: Expected earnings per share growth for next year|INDP - Earnings growth forecast for next year|Scinai (SCNI) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year CALI|AFMD (Affimed NV) - Earnings growth forecast for next year|Expected net earnings per share growth next year Allakos Therapeutics ALLK|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|IGMS (igmbio.com) - Expected earnings per share trend next year|Earnings growth forecast for next year ITOS (iTeos)|Consensus forecast of earnings per share growth for next year Ocean Biomedical Corp (OCEA)|TC Biopharm - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year thirdharmonicbio.com (THRD)
